Clinical Trials Update: Dec. 11, 2008
Melanoma Prostate Cancer Alzheimer Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you have a confirmed diagnosis of melanoma that is not surgically resectable, or metastatic Stage IV; and it has been at least four weeks since major surgery, immunotherapy, or radiation, cytokine, biologic or vaccine therapy; you may qualify for this study.
The research site is in Tulsa, Okla.
If you have confirmed metastatic prostate cancer, no more than one prior chemotherapy on which the disease progressed, and ECOG performance status of less than or equal to two, you may qualify for this study.
The research site is in Fountain Valley, Calif.
If you are aged 50 to 88, have mild-to-moderate Alzheimer's, and are living at home with a caregiver, you may be eligible for this study. People with pacemakers or other implanted metal devices are not eligible.
The research site is in Boulder, Colo.
Copyright 2008 CenterWatch. All rights reserved.